1st February, opening of the Biosafety L3 laboratory in the CRCT Technology Cluster

The Technology Cluster now benefits from a Biosafety L3 laboratory which contains three cubicles that are fully equipped for the production of viral vectors. Two are accessible to research teams from the Toulouse Cancer Research Centre, for the production of lentiviral vectors. The third cubicle is dedicated to the production of adenoviral and AAV vectors, the latter being produced on demand by the Platform’s staff. This L3 laboratory is managed by the Vectorology Platform, which also provides training for new users in the working procedures specific to this type of facility, and in the production of lentiviral vectors. For more information, you can contact Loïc VAN DEN BERGHE at: loic.vandenberghe@inserm.fr

Page 2 of 2
1 2